| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Alnylam Pharmaceuticals, Inc. (ALNY) has 11 insiders with recent SEC Form 4 filings, including 0 buys and 73 sells. ALNY is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 79.1K | $22.00M | - | |
| CFO | 58.4K | $16.24M | - | |
| VP | 29.8K | $8.28M | - | |
| VP | 23.7K | $6.59M | - | |
| Dir | 23.2K | $6.45M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 14, 2025 | Ausiello Dennis A | Director | Sale+OE | 31,448 | $436.58 | $13,729,535.65 | -17.6% | +2.3% | - | |
| Jun 2, 2025 | Greenstreet Yvonne49 | Chief Executive Officer | Sale+OE | 50,937 | $305.00 | $15,535,784.00 | -25.0% | +46.0% | -6.5% | |
| May 15, 2025 | Bonney Michael W | Director | Sale+OE | 11,250 | $277.71 | $3,124,216.94 | -3.4% | +52.6% | +1.3% | |
| Apr 16, 2025 | Reitan Colleen F69 | Director | Sell | 36 | $232.86 | $8,382.96 | -100% | +35.0% | - | |
| Mar 24, 2025 | Pyott David E I | Director | Sale+OE | 7,440 | $299.00 | $2,224,560.00 | -98.2% | +7.7% | +6.0% | |
| Mar 24, 2025 | Garg Pushkal50 | CMO &EVP Dev &Med Affairs | Sale+OE | 9,766 | $293.36 | $2,864,985.00 | -19.5% | +7.7% | +6.0% | |
| Mar 4, 2025 | Fitzgerald Kevin Joseph | CSO &EVP, Head Of Research | Sell | 2,755 | $242.94 | $669,304.07 | -1.3% | +26.0% | +34.7% | |
| Mar 4, 2025 | Garg Pushkal50 | CMO &EVP Dev &Med Affairs | Sell | 2,557 | $242.92 | $621,150.40 | -0.7% | +26.0% | +34.7% | |
| Mar 3, 2025 | Tanguler Tolga57 | EVP, Chief Commercial Officer | Sell | 471 | $243.78 | $114,820.42 | -0.3% | +25.7% | +30.9% | |
| Mar 3, 2025 | Poulton Jeffrey V.45 | EVP, Chief Financial Officer | Sell | 1,264 | $243.78 | $308,140.61 | -0.4% | +25.7% | +30.9% |